Astron Limited Successfully Completed Registration with the U.S. Food and Drug Administration (FDA) In 2026
Astron has successfully completed registration with the U.S. Food and Drug Administration (FDA) in 2026, marking an important milestone in our commitment to maintaining internationally recognized standards of quality, safety, and regulatory compliance.
Share on:
